HUNTINGTON, N.Y., Jan. 22, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical, a leader in innovative solutions targeting inflammation and metabolic health, proudly announces a financial and strategic investment from 5 Horizons Capital. Horizon, as the lead investor for the Phase 2 clinical...
Read More Details
Finally We wish PressBee provided you with enough information of ( Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizons Capital to Advance SJP-001 Clinical Trial with Novotech )
Also on site :
- 'Explosive-laden vehicle hit convoy': 16 Pakistan troops killed in suicide attack
- ‘Like a wastepaper basket’: Life as a child refugee fleeing home
- USPS slammed as ‘failed system’ after 1,000s of letters & packages found abandoned in mail centers following huge delays